Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

17.63
-0.2850-1.59%
Volume:405.74K
Turnover:7.22M
Market Cap:2.26B
PE:-43.82
High:18.10
Open:17.67
Low:17.52
Close:17.91
52wk High:19.76
52wk Low:7.07
Shares:128.00M
Float Shares:117.00M
Volume Ratio:0.41
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.87
PE(LYR):-20.90

Loading ...

NeoGenomics is Maintained at Buy by Needham

Dow Jones
·
Jul 29

Neogenomics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 29

GUIDANCE: (NEO) NeoGenomics Expects 2026 Revenue Range $802 Million-$806 Million, vs. FactSet Est of $800.4 Million

MT Newswires Live
·
Jul 29

Earnings Flash (NEO) NeoGenomics Posts Q2 Adjusted EPS $0.05, vs. FactSet Est of $0.03

MT Newswires Live
·
Jul 29

Neogenomics Shares Rise 6.5% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
Jul 29

NeoGenomics Q2 FY26 Adjusted Ebitda Climbs 36% to $14 Million; Revenue Rises 11% to $202 Million

Reuters
·
Jul 29

NeoGenomics Q2 Adj. EPS $0.05 Beats $0.03 Estimate, Sales $202.000M Beat $196.997M Estimate

Benzinga Earnings
·
Jul 29

NeoGenomics Q2 Revenue USD 202 Million Vs. IBES Estimate USD 197 Million

Reuters
·
Jul 29

Neogenomics Inc: Decrease in Operating Expenses for Q2 2026 was Primarily Due to $20 Mln of Impairment Charges Taken in Q2 2025

THOMSON REUTERS
·
Jul 29

Neogenomics Q2 Operating Expenses USD 102 Million

THOMSON REUTERS
·
Jul 29

Neogenomics: Sees Fy2026 Adj Ebitda $56 Mln to $58 MLN\n

THOMSON REUTERS
·
Jul 29

Neogenomics: Expects Fy2026 Net Loss of $42 Mln to $34 MLN\n

THOMSON REUTERS
·
Jul 29

Neogenomics Q2 Adjusted Ebitda USD 14 Million

THOMSON REUTERS
·
Jul 29

Neogenomics Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Jul 29

Press Release: NEO Battery Reports Fiscal Year 2027 First Quarter Results

Dow Jones
·
Jul 28

Neogenomics is Maintained at Buy by Benchmark

Dow Jones
·
Jul 24

NeoGenomics price target raised to $16 from $11 at Benchmark

TIPRANKS
·
Jul 24

Earning Preview: NeoGenomics Q2 revenue is expected to increase by 7.83%, and institutional views are bullish

Earnings Agent
·
Jul 22

How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors

Simply Wall St.
·
Jul 21

Neogenomics to Pay $9.8M to Resolve Allegations of False Claims Act Violation

Dow Jones
·
Jul 21